Using light as drug for neuro-degenerative disorders


Hubballi’s Dr. Yavagal mentors students of Asia-Pacific region


-: D. Ram Raj :-

Light as a drug for curing neuro-degenerative diseases may sound crazy, but that is indeed the truth of the matter. Dr. Chandrashekar Yavagal, the founder of LaserVEDA and the brain behind NovoLASE and Yavagal Healthcare Foundation in a two-tier town of Hubballi in Karnataka, is pioneering this effort across India and Asia-Pacific.

Dr. Yavagal is, in some senses, a chip of the old block as his late father Dr. Murugesh Yavagal was a people’s doctor specialising as a physician and allergy cure. Dr. Yavagal is the mentor for students across India and Asia-Pacific region on using light for neuro-degenerative diseases. “In simple terms, it means how to use light as a drug for oral diseases, pain of the head and neck, neurological disorders, including dementia and traumatic injuries…, basically where there is a neuro-degenerative component,” Dr. Yavagal told Trinity Mirror.

“I conduct this programme for a batch of eight students – four in-person from across India and four online from abroad under the aegis of the International College of Light Medicine and Laser Therapy, Germany. I train doctors, dentists and physiotherapists in this art and science of using laser and light for non-surgical purposes – for example by using this technique called photo bio-modulation or laser light in low intensity to treat Alzheimer’s, Parkinson’s, cognitive disturbances and other neuro-degenerative disturbances,” he explained.

Way back in 2006, as a fresh postgraduate specialist in dentistry, he faced the challenge of using laser on new born infant to remove a tumour kind of growth in the mouth without inducing bleeding.

With cost of equipment being the biggest hurdle, he also turned into an entrepreneur or rather a peoplepreneur (an entrepreneur who made innovative technology affordable to the common man) along with a group of IIT-educated Engineers to manufacture the laser treatment equipment at a cost of Rs. 99,000 during the coronavirus pandemic lockdown (the price of equipment in the market varied between Rs. 4 lakh and Rs. 10 lakh). The successful business venture has resulted in more than 100 such laser equipment being installed across India as well as Malaysia, Singapore and the Ethiopian capital of Addis Ababa. NovoLASE now has five variants of the equipment, including an exclusive product for paediatrics called NovoLASE Pedo.

He imbibed this desire to serve the people from his father, late Dr. Murugesh Yavagal (an allergy specialist and general physician) at a young age. His father’s overtly people-centric aptitude meant financial constraints at the very outset and Dr. Yavagal had to struggle to buy even simple equipment such as a skull during his dental surgery education. Hard work, determination and an innovative mindset to equip himself with the desired skills pushed him to pursue his passion to the highest level never ever bothered by the financial hurdles that would come his way. He completed his Master’s in Dental Surgery with specialisation in Paediatric Dentistry.

He went to Barcelona, Spain in 2008 to complete his Diploma in Orthodontics under a new system called Neuromuscular Orthodontics and Gnathology, which was not available in India. He spurned all job offers in foreign countries, especially from the Middle East, as he wanted to serve the people of his nation as a true son of the soil. He also completed his Ph.D., in Laser Biophotonics. In 2018, he became the first Indian Dentist to be invited to speak at the World Association for Laser Therapy at Nice, France. After that he received invites from Singapore, Kuwait Monaco and Monte Carlo. He has published more than 70 papers in peer reviewed journals and has conducted more than 300 lectures, workshops and webinars on Lasers, Paediatric, Preventive and Restorative Dentistry in India, Singapore, Kuwait, France and Spain. He is now turning out to be a quintessential Globalpreneur by innovating and imparting knowledge on ‘light’ as a drug for neuro-degenerative treatment.



See also:

Grandma in the Boardroom: Invoking ancient folkore lore for an IT narrative

Edu~Edge: Debunking the myths of Standard English



, , ,

Leave a Reply

Your email address will not be published. Required fields are marked *